The Innovation Center for Advanced Therapies (ICAT), part of UMC Utrecht, has moved into Plus Ultra Utrecht at Utrecht Science Park. This step strengthens the regional infrastructure for regenerative medicine and supports the activities of the RegMed XB Pilot Factory.

BioGeneration Ventures (BGV) has announced the close of FIRST II (Fonds InvesteringsRijpe Starters), reaching 12 million euro to support the creation and development of early-stage life sciences start-ups emerging from Dutch academic research.

From 18–20 February, RegMed XB proudly hosted a high-level Japanese delegation as part of an intensive knowledge exchange visit between the Netherlands and Japan. The delegation included representatives from Nakanoshima Qross, Cuorips Inc., and Rege Nephro Co., Ltd..